I agree that this site is using cookies. You can find further informations here.
X
O'Dwyer, Michael
654  results:
Search for persons X
?
1

Hypersialylation and multiple myeloma:

O'Dwyer, Michael ; Glavey, Siobhan ; McAvera, Roisin..
Frontiers in Hematology.  3 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

PSGL-1 decorated with sialyl Lewisa/x promotes high affinit..:

O'Dwyer, Michael ; Kirkham-McCarthy, Lucy ; Cerreto, Marina..
Scientific Reports.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
3

Steroid-free combination of 5-azacytidine and venetoclax fo..:

Flanagan, Lyndsey ; Coughlan, Aisling ; Cosgrove, Nicola...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
4

Sialofucosylation Enables Platelet Binding to Myeloma Cells..:

Natoni, Alessandro ; Cerreto, Marina ; De Propris, Maria Stefania...
Cancers.  15 (2023)  7 - p. 2154 , 2023
Link: https://doi.org/10.3390/..
 
?
5

A Transcriptomic Approach to Understand Patient Susceptibil..:

Torrance, Hew D. ; Zhang, Ping ; Longbottom, E. Rebecca...
Annals of Surgery.  279 (2023)  3 - p. 510-520 , 2023
Link: https://doi.org/10.1097/..
 
?
6

Adoptive Immunotherapy and High-Risk Myeloma:

Duane, Catherine ; O'Dwyer, Michael ; Glavey, Siobhan
Cancers.  15 (2023)  9 - p. 2633 , 2023
Link: https://doi.org/10.3390/..
 
?
7

P-018: Optimized affinity CD38 CAR-NK cells with CD38 KO sh..:

O'Dwyer, Michael ; Shevlin, Enda ; Brophy, Sarah...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S45-S46 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Feeder Cells at the Interface of Natural Killer Cell Activa..:

Gurney, Mark ; Kundu, Soumyadipta ; Pandey, Shubham.
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
9

Corrigendum to "Hypoxia Impairs NK Cell Cytotoxicity throug..:

Teng, Rui ; Wang, Yanmeng ; Lv, Nan...
Journal of Immunology Research.  2021 (2021)  - p. 1-1 , 2021
Link: https://doi.org/10.1155/..
 
?
10

How to Simplify the Evaluation of Newly Introduced Chemothe..:

Cook, Gordon ; Alvarez-Iglesias, Alberto ; Cairns, David A....
Clinical Hematology International.  3 (2021)  1 - p. 27 , 2021
Link: https://doi.org/10.2991/..
 
?
11

MM-155: Phase 3 MAIA Study: Overall Survival (OS) Results w..:

Orlowski, Robert ; Facon, Thierry ; Kumar, Shaji...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S424-S425 , 2021
Link: https://doi.org/10.1016/..
 
?
12

Cyclophosphamide alters the tumor cell secretome to potenti..:

Naicker, Serika D ; Feerick, Claire L ; Lynch, Kevin...
OncoImmunology.  10 (2021)  1 - p. , 2021
Link: https://doi.org/10.1080/..
 
?
13

CD38-specific Chimeric Antigen Receptor Expressing Natural ..:

Stikvoort, Arwen ; van der Schans, Jort ; Sarkar, Subhashis...
HemaSphere.  5 (2021)  7 - p. e596 , 2021
Link: https://doi.org/10.1097/..
 
?
14

Poster: MM-155: Phase 3 MAIA Study: Overall Survival (OS) R..:

Orlowski, Robert ; Facon, Thierry ; Kumar, Shaji...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S252 , 2021
Link: https://doi.org/10.1016/..
 
?
15

P-094: ABT-199 and epigenetic modifiers: promising novel co..:

Flanagan, Lyndsey ; Chonghaile, Triona Ní ; Glavey, Siobhan.
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S90 , 2021
Link: https://doi.org/10.1016/..
 
1-15
Related subjects
Chemische Bindung